A Systematic Review and Meta-Analysis of Comparison of Outcomes of Robot-Assisted versus Open Partial Nephrectomy in Clinical T1 Renal Cell Carcinoma Patients

Author:

Ni Yixiu,Yang Xiaohua

Abstract

<b><i>Introduction:</i></b> Robot-assisted partial nephrectomy (RAPN) has been increasingly used for renal cell carcinoma in recent years. But the advantages of RARN over open partial nephrectomy (OPN) are still controversial. <b><i>Methods:</i></b> We searched the articles between 1997 and 2021 in PubMed, Web of Science, Cochrane Library, and EMbase databases. The parameters were perioperative outcomes including operating time (OT), warm ischemic time (WIT), estimated blood loss (EBL), positive surgical margin (PSM), preoperative and postoperative estimated glomerular filtration rate (eGFR), length of stay (LOS), and intraoperative and postoperative complications. Stata 13.0 software was used for the meta-analysis. <b><i>Results:</i></b> Seven studies with 2,646 patients (1,285 in RAPN vs. 1,361 in OPN) were included in the analysis. There were no significant differences in OT (WMD [95% confidence interval (CI)]: 0.14 [−0.33, 0.61], <i>p</i> = 0.570); WIT (WMD [95% CI]:0.28 [−0.13, 0.69], <i>p</i> = 0.187); PSM (odds ratio [OR] [95% CI]: 1.04 [0.37, 2.94], <i>p</i> = 0.944); preoperative eGFR (OR [95% CI]: 0.11 [−0.01, 0.23], <i>p</i> = 0.071); postoperative eGFR (OR [95% CI]: −0.11 [0.27, 0.04], <i>p</i> = 0.159); and intraoperative complications (OR [95% CI]: 0.13 [0.02, 1.04], <i>p</i> = 0.055) between 2 groups. But there were still less EBL (WMD [95% CI]: −0.67 [−1.07, −0.28], <i>p</i> = 0.001), shorter LOS (WMD [95% CI]: −1.09 [−1.86, −0.32], <i>p</i> = 0.005) and fewer postoperative complications (OR [95% CI]: 0.51 [0.38, 0.68], <i>p</i> = 0.000). <b><i>Conclusions:</i></b> Compared with OPN, RAPN appears to achieve partly similar short-term functional outcomes. Meanwhile, some results are inconsistent with previous studies which seem to show that tumor type is also an important factor in comparison between RAPN and OPN, but the analysis is not carried out due to lack of complete data. Therefore, more high-quality random controlled trials are acquired.

Publisher

S. Karger AG

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3